Skip to Content
Morningstar

Columbia Research Enhanced Value ETF REVS

Morningstar Medalist Rating
Medalist Rating as of | See Columbia Threadneedle Investment Hub

Morningstar’s Analysis REVS

Will REVS outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

  • Process Pillar

    The Process Pillar is our assessment of how sensible, clearly defined, and repeatable REVS’s performance objective and investment process is for both security selection and portfolio construction.

  • People Pillar

    The People Pillar is our evaluation of the REVS management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.

  • Parent Pillar

    The Parent Pillar is our rating of REVS’s parent organization’s priorities and whether they’re in line with investors’ interests.

The combination of a middling Process Pillar rating and a Below Average People Pillar rating limit Columbia Research Enhanced Value ETF to a Morningstar Medalist Rating of Neutral.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The portfolio maintains a cost advantage over competitors, priced within the least expensive fee quintile among peers.

by Morningstar Manager Research
Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings REVS

More REVS Holdings
  • Current Portfolio Date
  • Equity Holdings —
  • Bond Holdings —
  • Other Holdings —
  • % Assets in Top 10 Holdings 28.7
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

JPMorgan Chase & Co

5.01 2.6 Mil
Financial Services

Johnson & Johnson

4.93 2.5 Mil
Healthcare

Exxon Mobil Corp

3.35 1.7 Mil
Energy

Cisco Systems Inc

3.15 1.6 Mil
Technology

Bank of America Corp

2.93 1.5 Mil
Financial Services

Wells Fargo & Co

2.25 1.1 Mil
Financial Services

Philip Morris International Inc

2.17 1.1 Mil
Consumer Defensive

Chevron Corp

1.76 897,321
Energy

Caterpillar Inc

1.69 865,206
Industrials

Medtronic PLC

1.42 726,633
Healthcare